Does Dr. NIRAV PATEL have financial conflicts of interest?

Dr. NIRAV PATEL (M.D.) has received a total of $495,784 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $494,198 in personal promotional payouts (consulting, meals, travel) and $1,586 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. NIRAV PATEL?

According to CMS Open Payments data, Dr. NIRAV PATEL received funding from ASTRAZENECA PHARMACEUTICALS ($280,785), LILLY USA ($55,480), and ALEXION PHARMACEUTICALS ($44,287).

Does Dr. NIRAV PATEL receive research grants or speaking fees?

Dr. NIRAV PATEL has received $494,198 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $1,586 in clinical research grants.

DR. NIRAV PATEL

M.D.Real-Time Hydrated

Specialty: Psychiatry & Neurology, Neurology

Practice Location: LOS ALAMITOS, CA 90720

NPI Number: 1881631539

LIFETIME INDUSTRY VALUE

$495,784

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. PATEL is a verified Psychiatry & Neurology, Neurology practitioner based in LOS ALAMITOS, CA.

Between 2021 and 2024, Dr. PATEL had an overall industry promotional and research financial footprint of $495,784 as recorded in the federal CMS Open Payments database.

$494,198 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$1,586 was allocated to sponsored clinical trials and medical research activities.

Dr. PATEL's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $280,785 (representing 56.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$280,785

56.6%

LILLY USA

Rank 2

$55,480

11.2%

ALEXION PHARMACEUTICALS

Rank 3

$44,287

8.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.